Medicare Enrolled

Dr. John Weinhold, MD

Medical Oncology · Olean, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
535 MAIN ST, Olean, NY 14760
7163720141
Registered in NPPES since 2005
NPI: 1265417737 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weinhold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weinhold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weinhold

Dr. John Weinhold is a medical oncology specialist in Olean, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weinhold performed 668 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Weinhold received a total of $11,719 from 56 pharmaceutical and/or device companies across 640 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weinhold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 28% volume in NY $11,719 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
668
Medicare services
Top 28% in NY for medical oncology
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
340 $69 $228
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
220 $101 $318
New patient office visit, complex (60-74 min) 36 $123 $450
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
26 $91 $220
Same-day hospital admission and discharge, high complexity
Initial hospital care for a patient admitted and discharged on the same day, involving a high level of medical decision making. This service requires at least 85 minutes of time spent on the day of the visit.
25 $160 $490
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $61 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,719
Total received (2018-2024)
Avg $1,674/year across 7 years
Top 42% in NY for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
640
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,223
2023
$720
2022
$212
2021
$31
2020
$2,414
2019
$3,440
2018
$3,679

Payments by company (2024)

GENZYME CORPORATION
$261
Janssen Biotech, Inc.
$152
AstraZeneca Pharmaceuticals LP
$125
Astellas Pharma US Inc
$82
ABBVIE INC.
$77
Daiichi Sankyo Inc.
$61
Regeneron Healthcare Solutions, Inc.
$56
Incyte Corporation
$53
Genentech USA, Inc.
$51
PFIZER INC.
$39
Coherus Biosciences Inc.
$34
Genmab U.S., Inc.
$30
Tactile Systems Technology Inc
$26
Merck Sharp & Dohme LLC
$26
Lilly USA, LLC
$23
Gilead Sciences, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$21
Exelixis Inc.
$21
Novartis Pharmaceuticals Corporation
$19
Karyopharm Therapeutics Inc.
$16
E.R. Squibb & Sons, L.L.C.
$16
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$926
E.R. Squibb & Sons, L.L.C.
$870
Amgen Inc.
$867
Novartis Pharmaceuticals Corporation
$845
Janssen Biotech, Inc.
$746
AstraZeneca Pharmaceuticals LP
$718
PFIZER INC.
$651
Pharmacyclics LLC, An AbbVie Company
$575
GENZYME CORPORATION
$573
Celgene Corporation
$518
Genentech USA, Inc.
$492
Incyte Corporation
$431
Astellas Pharma US Inc
$366
Daiichi Sankyo Inc.
$329
Clovis Oncology, Inc.
$310
Lilly USA, LLC
$303
AbbVie, Inc.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$118
Regeneron Healthcare Solutions, Inc.
$114
Alexion Pharmaceuticals, Inc.
$112
BeiGene USA, Inc.
$97
CSL Behring
$96
Rigel Pharmaceuticals, Inc.
$89
ARRAY BIOPHARMA INC
$82
Apellis Pharmaceuticals, Inc.
$79
ABBVIE INC.
$77
Puma Biotechnology, Inc.
$65
Eisai Inc.
$64
Seagen Inc.
$64
EISAI INC.
$64
Gilead Sciences, Inc.
$55
Verastem, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$50
Sun Pharmaceutical Industries Inc.
$48
Tactile Systems Technology Inc
$47
Taiho Oncology, Inc.
$46
Merck Sharp & Dohme LLC
$46
Ipsen Biopharmaceuticals, Inc
$42
TOLMAR Pharmaceuticals, Inc.
$38
GlaxoSmithKline, LLC.
$37
Coherus Biosciences Inc.
$34
Genmab U.S., Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$27
EMD Serono, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$22
Teva Pharmaceuticals USA, Inc.
$22
Exelixis Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
TAIHO ONCOLOGY, INC.
$18
Shire North American Group Inc
$17
Karyopharm Therapeutics Inc.
$16
Lexicon Pharmaceuticals, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
APTEVO THERAPEUTICS INC
$14
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · CYRAMZA · Columvi · Copiktra · DARZALEX · ELIGARD · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · Flexitouch Plus · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · IXINITY · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · ODOMZO · OPDIVO · OPDUALAG · Onivyde · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIAGRA · VONVENDI · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · XYNTHA · Xermelo · Xofigo · Xtandi · YONSA · ZEPOSIA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Olean?
Compare medical oncologists in the Olean area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
2
County median income
$58,248
Nearest hospital to ZIP centroid (approximate)
OLEAN GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weinhold is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NY), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weinhold experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weinhold performed 340 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Weinhold receive payments from pharmaceutical companies?
Yes. Dr. Weinhold received a total of $11,719 from 56 companies across 640 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weinhold's costs compare to other medical oncologists in Olean?
Dr. Weinhold's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weinhold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →